| Sexual behaviour of heterosexual men and women receiving antiretroviral pre-exposure prophylaxis for HIV prevention: a longitudinal analysis KK Mugwanya, D Donnell, C Celum, KK Thomas, P Ndase, N Mugo, ... The Lancet infectious diseases 13 (12), 1021-1028, 2013 | 147 | 2013 |
| Pre-exposure prophylaxis uptake and early continuation among pregnant and post-partum women within maternal and child health clinics in Kenya: results from an implementation … J Kinuthia, J Pintye, F Abuna, KK Mugwanya, H Lagat, D Onyango, ... The lancet HIV 7 (1), e38-e48, 2020 | 137 | 2020 |
| Integrating preexposure prophylaxis delivery in routine family planning clinics: a feasibility programmatic evaluation in Kenya KK Mugwanya, J Pintye, J Kinuthia, F Abuna, H Lagat, ER Begnel, ... PLoS medicine 16 (9), e1002885, 2019 | 134 | 2019 |
| Changes in glomerular kidney function among hiv-1–uninfected men and women receiving emtricitabine–tenofovir disoproxil fumarate preexposure prophylaxis: A randomized clinical … KK Mugwanya, C Wyatt, C Celum, D Donnell, NR Mugo, J Tappero, ... JAMA internal medicine 175 (2), 246-254, 2015 | 132 | 2015 |
| Pre-exposure prophylaxis use by breastfeeding HIV-uninfected women: a prospective short-term study of antiretroviral excretion in breast milk and infant absorption KK Mugwanya, CW Hendrix, NR Mugo, M Marzinke, ET Katabira, K Ngure, ... PLoS medicine 13 (9), e1002132, 2016 | 100 | 2016 |
| Scaling-up PrEP delivery in sub-Saharan Africa: what can we learn from the scale-up of ART? G O’Malley, G Barnabee, K Mugwanya Current HIV/AIDS Reports 16, 141-150, 2019 | 79 | 2019 |
| An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda C Psaros, JE Haberer, E Katabira, A Ronald, E Tumwesigye, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 66 (5), 522-529, 2014 | 77 | 2014 |
| Reversibility of glomerular renal function decline in HIV-uninfected men and women discontinuing emtricitabine-tenofovir disoproxil fumarate pre-exposure prophylaxis KK Mugwanya, C Wyatt, C Celum, D Donnell, J Kiarie, A Ronald, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 71 (4), 374-380, 2016 | 76 | 2016 |
| Brief report: integration of PrEP services into routine antenatal and postnatal care: experiences from an implementation program in Western Kenya J Pintye, J Kinuthia, DA Roberts, AD Wagner, K Mugwanya, F Abuna, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 79 (5), 590-595, 2018 | 74 | 2018 |
| High-dose valacyclovir HSV-2 suppression results in greater reduction in plasma HIV-1 levels compared with standard dose acyclovir among HIV-1/HSV-2 coinfected persons: a … K Mugwanya, JM Baeten, NR Mugo, E Irungu, K Ngure, C Celum The Journal of infectious diseases 204 (12), 1912-1917, 2011 | 58 | 2011 |
| Low risk of proximal tubular dysfunction associated with emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis in men and women K Mugwanya, J Baeten, C Celum, D Donnell, T Nickolas, N Mugo, ... The Journal of infectious diseases 214 (7), 1050-1057, 2016 | 57 | 2016 |
| Acceptability and outcomes of distributing HIV self-tests for male partner testing in Kenyan maternal and child health and family planning clinics J Pintye, AL Drake, E Begnel, J Kinuthia, F Abuna, H Lagat, J Dettinger, ... Aids 33 (8), 1369-1378, 2019 | 56 | 2019 |
| Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention KK Mugwanya, JM Baeten Expert opinion on drug safety 15 (2), 265-273, 2016 | 48 | 2016 |
| “I just believe there is a risk” understanding of undetectable equals untransmissible (U= U) among health providers and HIV‐negative partners in serodiscordant relationships in … K Ngure, F Ongolly, A Dolla, M Awour, KK Mugwanya, E Irungu, N Mugo, ... African Journal of Reproduction and Gynaecological Endoscopy 23 (3), e25466, 2020 | 47 | 2020 |
| Elevations in serum creatinine with tenofovir-based HIV pre-exposure prophylaxis: a meta-analysis of randomized placebo-controlled trials R Yacoub, GN Nadkarni, D Weikum, I Konstantinidis, A Boueilh, RM Grant, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 71 (4), e115-e118, 2016 | 45 | 2016 |
| Two-way short message service (SMS) communication may increase pre-exposure prophylaxis continuation and adherence among pregnant and postpartum women in Kenya J Pintye, Z Rogers, J Kinuthia, KK Mugwanya, F Abuna, H Lagat, J Sila, ... Global Health: Science and Practice 8 (1), 55-67, 2020 | 40 | 2020 |
| Perinatal outcomes following maternal pre‐exposure prophylaxis (Pr EP) use during pregnancy: results from a large Pr EP implementation program in Kenya JC Dettinger, J Kinuthia, J Pintye, F Abuna, E Begnel, K Mugwanya, J Sila, ... Journal of the International AIDS Society 22 (9), e25378, 2019 | 39 | 2019 |
| Tenofovir and tenofovir-diphosphate concentrations during pregnancy among HIV-uninfected women using oral preexposure prophylaxis M Pyra, PL Anderson, CW Hendrix, R Heffron, K Mugwanya, JE Haberer, ... Aids 32 (13), 1891-1898, 2018 | 39 | 2018 |
| “I just decided to stop:” understanding PrEP discontinuation among individuals initiating PrEP in HIV care centers in Kenya FK Ongolly, A Dolla, K Ngure, EM Irungu, J Odoyo, E Wamoni, K Peebles, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 87 (1), e150-e158, 2021 | 37 | 2021 |
| Scale up of PrEP integrated in public health HIV care clinics: a protocol for a stepped-wedge cluster-randomized rollout in Kenya KK Mugwanya, E Irungu, E Bukusi, NR Mugo, J Odoyo, E Wamoni, ... Implementation Science 13, 1-11, 2018 | 30 | 2018 |
